{"id":"W3001602950","doi":"10.1097/ogx.0000000000000756","title":"Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer","year":2020,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; Aalborg Universitet; Pacira BioSciences; Mylan; Fujirebio US; Clovis Oncology; Pacira Pharmaceuticals; Gentofte Hospital; University of South Carolina; Eisai; Thomas Jefferson University; McGill University Health Centre; McGill University; Karyopharm Therapeutics; Roche; GlaxoSmithKline; Takeda Oncology; Rigshospitalet; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Taxane; Epithelial ovarian cancer; Regimen; Ovarian cancer; Chemotherapy; Oncology; Internal medicine; Cytoreductive surgery; Gynecology; Cancer; Breast cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003399314,0.0001437899,0.0004710057,0.000300155,0.0001495853,0.0003094698,0.0001714337,0.0003766382,0.001705383],"category_scores_gemma":[0.001384705,0.0001187232,0.0003817303,0.000599216,0.0001356066,0.0002971633,0.0001931029,0.0006910128,0.0003125565],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002488403,"about_ca_system_score_gemma":0.0004118683,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001310915,"about_ca_topic_score_gemma":0.00371972,"domain_scores_codex":[0.999808,0.00006573541,0.00002171639,0.00002914695,0.00004750398,0.0000279176],"domain_scores_gemma":[0.9995627,0.0001389889,0.0001313781,0.00001548559,0.00002719868,0.0001242928],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01238705,0.0005827977,0.7909186,0.0007967763,0.0005342588,0.002271571,0.0001192347,0.0007394805,0.001692355,0.0002222113,0.02255124,0.1671844],"study_design_scores_gemma":[0.002717066,0.002724888,0.9705989,0.0001983764,0.0005013638,0.004064496,0.00019995,0.0009009861,0.0003733898,0.0004135717,0.01727658,0.000030497],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.896846,0.07293254,0.0002426051,0.006311582,0.001026174,0.0001568098,0.005269249,0.00007002944,0.017145],"genre_scores_gemma":[0.9747966,0.0185078,0.0001920445,0.001593703,0.0007122441,0.00006464904,0.002253843,0.000005388337,0.001873829],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001705383,"threshold_uncertainty_score":0.005705059,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04237501895086256,"score_gpt":0.2939501556881457,"score_spread":0.2515751367372832,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}